A detailed history of Scientech Research LLC transactions in Incyte Corp stock. As of the latest transaction made, Scientech Research LLC holds 7,985 shares of INCY stock, worth $657,484. This represents 0.1% of its overall portfolio holdings.

Number of Shares
7,985
Previous 8,840 9.67%
Holding current value
$657,484
Previous $504 Million 3.88%
% of portfolio
0.1%
Previous 0.27%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$51.18 - $63.75 $43,758 - $54,506
-855 Reduced 9.67%
7,985 $484 Million
Q1 2024

May 15, 2024

BUY
$56.55 - $66.59 $499,902 - $588,655
8,840 New
8,840 $504 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $18.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Scientech Research LLC Portfolio

Follow Scientech Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scientech Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scientech Research LLC with notifications on news.